Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esflurbiprofen topical patch in acute ankle sprains
NCT06866613Phase 3Completed
- Sponsor
- Teikoku Seiyaku Co., Ltd.
- Start
- Mar 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of esflurbiprofen in Ankle sprain (2 arms), sponsored by Teikoku Seiyaku Co., Ltd. Primary endpoint: Sum of Pain Intensity Difference on pain-on-movement over 0-48 hours. Started Mar 2025; status: completed.
02
Drugs
esflurbiprofen
03
Conditions
Ankle sprain
Beyond the preview
Go deeper on NCT06866613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06866613.